Axsome Therapeutics Inc. (AXSM) NASDAQ
$79.80 0.63 (0.80%)
Market Cap: $3.75B
As of 03/28/24 04:00 PM EDT. Market closed.
Axsome Therapeutics Inc. (AXSM)
NASDAQ
$79.80
0.63 (0.80%)
Market Cap: $3.75B
As of 03/28/24 04:00 PM EDT. Market closed.
axsome therapeutics is a biopharmaceutical company developing novel therapies for the treatment of cns disorders. axsome has a balanced portfolio of clinical development stage as well as research stage product candidates. the company is based in new york ... read more
axsome therapeutics is a biopharmaceutical company developing novel therapies for the treatment of cns disorders. axsome has a balanced portfolio of clinical development stage as well as research stage product candidates. the company is based in new york city. read less
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
JEFFS ROGER | Director | Mar 14, 2024 | Option Exercise | $24.01 | 29,976 | 719,787 | 137,732 | Mar 15, 2024, 08:05 PM |
JEFFS ROGER | Director | Mar 15, 2024 | Option Exercise | $29.91 | 2,347 | 70,199 | 123,103 | Mar 15, 2024, 08:05 PM |
JEFFS ROGER | Director | Mar 14, 2024 | Sale | $69.70 | 29,976 | 2,089,387 | 120,756 | Mar 15, 2024, 08:05 PM |
JEFFS ROGER | Director | Mar 15, 2024 | Sale | $71.61 | 2,347 | 168,062 | 120,756 | Mar 15, 2024, 08:05 PM |
Coleman Mark | Director | Sep 15, 2023 | Option Exercise | $3.67 | 11,016 | 40,429 | 36,113 | Sep 15, 2023, 06:30 PM |
Coleman Mark | Director | Sep 15, 2023 | Sale | $75.18 | 18,572 | 1,396,189 | 403,856 | Sep 15, 2023, 06:30 PM |
Coleman Mark | Director | Sep 15, 2023 | Sale | $75.19 | 11,016 | 828,241 | 25,097 | Sep 15, 2023, 06:30 PM |
Coleman Mark | Director | Jan 03, 2023 | Option Exercise | $1.30 | 17,501 | 22,751 | 25,097 | Jan 04, 2023, 04:11 PM |
Coleman Mark | Director | Mar 15, 2022 | Option Exercise | $1.30 | 3,496 | 4,545 | 7,596 | Mar 17, 2022, 07:05 AM |
JEFFS ROGER | Director | Nov 19, 2021 | Buy | $37.30 | 3,950 | 147,350 | 120,756 | Nov 23, 2021, 07:30 AM |
Pizzie Nick | CHIEF FINANCIAL OFFICER | Nov 18, 2021 | Buy | $34.97 | 428 | 14,968 | 201 | Nov 22, 2021, 07:31 AM |
Pizzie Nick | CHIEF FINANCIAL OFFICER | Nov 18, 2021 | Buy | $35.50 | 527 | 18,709 | 41,789 | Nov 22, 2021, 07:31 AM |
Coleman Mark | Director | Nov 18, 2021 | Buy | $35.09 | 1,430 | 50,181 | 422,428 | Nov 22, 2021, 07:30 AM |
Saad Mark E | Director | Nov 17, 2021 | Buy | $34.42 | 300 | 10,325 | 100 | Nov 19, 2021, 07:30 AM |
Saad Mark E | Director | Nov 17, 2021 | Buy | $34.53 | 3,000 | 103,597 | 10,002 | Nov 19, 2021, 07:30 AM |
Coleman Mark | Director | May 12, 2021 | Buy | $58.15 | 500 | 29,075 | 420,998 | May 13, 2021, 07:05 AM |
Coleman Mark | Director | Jun 29, 2020 | Buy | $78.50 | 650 | 51,025 | 403,698 | Jun 30, 2020, 08:20 AM |
Pizzie Nick | Chief Financial Officer | Jun 29, 2020 | Buy | $76.64 | 777 | 59,549 | 41,217 | Jun 30, 2020, 08:19 AM |
JEFFS ROGER | Director | Jan 10, 2020 | Option Exercise | $10.46 | 60,186 | 629,756 | 116,806 | Jan 14, 2020, 04:08 PM |
Pizzie Nick | Chief Financial Officer | Sep 26, 2019 | Buy | $24.80 | 2,180 | 54,064 | 40,440 | Sep 30, 2019, 07:16 AM |
JEFFS ROGER | Director | Jul 03, 2019 | Option Exercise | $3.04 | 56,620 | 172,178 | 56,620 | Jul 05, 2019, 07:00 AM |
Coleman Mark | Director | Jun 26, 2019 | Buy | $23.10 | 15,800 | 364,980 | 668,848 | Jun 27, 2019, 07:18 AM |
Coleman Mark | Director | Jun 25, 2019 | Buy | $23.25 | 400 | 9,300 | 653,048 | Jun 27, 2019, 07:18 AM |
Pizzie Nick | Chief Financial Officer | Jun 11, 2019 | Buy | $20.80 | 1,920 | 39,936 | 1,920 | Jun 12, 2019, 07:00 AM |
Saad Mark E | Director | May 23, 2019 | Buy | $22.33 | 3,500 | 78,155 | 7,002 | May 24, 2019, 07:19 AM |
Coleman Mark | Director | May 13, 2019 | Buy | $21.44 | 4,650 | 99,696 | 652,648 | May 15, 2019, 07:21 AM |
Pizzie Nick | Chief Financial Officer | Mar 19, 2019 | Buy | $12.58 | 5,340 | 67,177 | 36,340 | Mar 21, 2019, 07:05 AM |
Pizzie Nick | Chief Financial Officer | Mar 19, 2019 | Buy | $12.69 | 60 | 761 | 60 | Mar 21, 2019, 07:05 AM |
Coleman Mark | Director | Mar 19, 2019 | Buy | $12.18 | 5,100 | 62,118 | 5,100 | Mar 21, 2019, 07:05 AM |
Pizzie Nick | Chief Financial Officer | Jun 19, 2018 | Buy | $3.10 | 31,000 | 96,080 | 31,000 | Jun 20, 2018, 05:00 PM |
JEFFS ROGER | Director | Mar 29, 2017 | Option Exercise | $4.73 | 42,538 | 201,163 | 46,912 | Mar 30, 2017, 04:31 PM |
Kaye Randall | Chief Medical Officer | Dec 23, 2015 | Buy | $9.03 | 1,000 | 9,026 | 6,022 | Dec 24, 2015, 01:02 PM |
Ames Constance | Vice President, Finance | Nov 24, 2015 | Option Exercise | $5.94 | 4,358 | 25,887 | 4,358 | Nov 24, 2015, 04:26 PM |
Kaye Randall | Chief Medical Officer | Nov 24, 2015 | Option Exercise | $5.40 | 5,022 | 27,119 | 5,022 | Nov 24, 2015, 04:26 PM |
Coleman Mark | Director | Nov 24, 2015 | Option Exercise | $5.71 | 564,948 | 3,224,166 | 647,998 | Nov 24, 2015, 04:25 PM |
JEFFS ROGER | Director | Nov 24, 2015 | Option Exercise | $5.94 | 4,374 | 25,982 | 4,374 | Nov 24, 2015, 04:25 PM |
Saad Mark E | Director | Nov 24, 2015 | Option Exercise | $5.94 | 3,502 | 20,802 | 3,502 | Nov 24, 2015, 04:24 PM |
TABUTEAU HERRIOT | Chief Executive Officer | Nov 24, 2015 | Option Exercise | $5.94 | 7,229 | 42,940 | 7,229 | Nov 24, 2015, 04:24 PM |
Owner | Relationship | Date | Value($) |
JEFFS ROGER | Director | 03/14/2024 | 719,787 |
JEFFS ROGER | Director | 03/15/2024 | 70,199 |
JEFFS ROGER | Director | 03/14/2024 | 2,089,387 |
JEFFS ROGER | Director | 03/15/2024 | 168,062 |
Coleman Mark | Director | 09/15/2023 | 40,429 |
Coleman Mark | Director | 09/15/2023 | 1,396,189 |
Coleman Mark | Director | 09/15/2023 | 828,241 |
Coleman Mark | Director | 01/03/2023 | 22,751 |
Coleman Mark | Director | 03/15/2022 | 4,545 |
JEFFS ROGER | Director | 11/19/2021 | 147,350 |
Pizzie Nick | CHIEF FINANCIAL OFFICER | 11/18/2021 | 14,968 |
Pizzie Nick | CHIEF FINANCIAL OFFICER | 11/18/2021 | 18,709 |
Coleman Mark | Director | 11/18/2021 | 50,181 |
Saad Mark E | Director | 11/17/2021 | 10,325 |
Saad Mark E | Director | 11/17/2021 | 103,597 |
Coleman Mark | Director | 05/12/2021 | 29,075 |
Coleman Mark | Director | 06/29/2020 | 51,025 |
Pizzie Nick | Chief Financial Officer | 06/29/2020 | 59,549 |
JEFFS ROGER | Director | 01/10/2020 | 629,756 |
Pizzie Nick | Chief Financial Officer | 09/26/2019 | 54,064 |
JEFFS ROGER | Director | 07/03/2019 | 172,178 |
Coleman Mark | Director | 06/26/2019 | 364,980 |
Coleman Mark | Director | 06/25/2019 | 9,300 |
Pizzie Nick | Chief Financial Officer | 06/11/2019 | 39,936 |
Saad Mark E | Director | 05/23/2019 | 78,155 |
Coleman Mark | Director | 05/13/2019 | 99,696 |
Pizzie Nick | Chief Financial Officer | 03/19/2019 | 67,177 |
Pizzie Nick | Chief Financial Officer | 03/19/2019 | 761 |
Coleman Mark | Director | 03/19/2019 | 62,118 |
Pizzie Nick | Chief Financial Officer | 06/19/2018 | 96,080 |
JEFFS ROGER | Director | 03/29/2017 | 201,163 |
Kaye Randall | Chief Medical Officer | 12/23/2015 | 9,026 |
Ames Constance | Vice President, Finance | 11/24/2015 | 25,887 |
Kaye Randall | Chief Medical Officer | 11/24/2015 | 27,119 |
Coleman Mark | Director | 11/24/2015 | 3,224,166 |
JEFFS ROGER | Director | 11/24/2015 | 25,982 |
Saad Mark E | Director | 11/24/2015 | 20,802 |
TABUTEAU HERRIOT | Chief Executive Officer | 11/24/2015 | 42,940 |
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
BLACKROCK INC. | 3,239,746 | 0.00657% | 10.4% | Other |
RA CAPITAL MANAGEMENT, L.P. | 1,000,000 | 1.24% | No change | Other |
GEODE CAPITAL MANAGEMENT, LLC | 822,304 | 0.00685% | 5.63% | Other |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 365,000 | 0.06% | 12.31% | Other |
DRIEHAUS CAPITAL MANAGEMENT LLC | 265,842 | 0.25% | 6.81% | Growth |
FARALLON CAPITAL MANAGEMENT LLC | 4,000 | 0.00158% | -96.82% | Event Driven, Value |
WCM INVESTMENT MANAGEMENT, LLC | 104,808 | 0.02% | 9.22% | Growth At A Reasonable Price |
HHLR ADVISORS, LTD. | 100,000 | 0.16% | Exited | Other |
CANDRIAM S.C.A. | 85,084 | 0.05% | 69.88% | Other |
ALPS ADVISORS INC | 32,482 | 0.02% | -6.74% | Other |
D. E. SHAW & CO., INC. | 34,600 (Call) | 0.00241% | No change | Other |
UBS OCONNOR LLC | 11,922 | 0.07% | -53.67% | Value |
AQR CAPITAL MANAGEMENT LLC | 8,330 | 0.00125% | -14.66% | Other |
D. E. SHAW & CO., INC. | 9,184 | 0.00064% | New | Other |
Period of Report: 12/31/2023
10-K/10-Q Filings: View